Endometriosis, one of the most common benign gynecological diseases, affects millions of women of childbearing age. Endometriosis-associated pain is a major cause of disability and compromised quality of life in women. Neuropathic mechanisms are believed to play an important role. An imbalanced sympathetic and sensory innervation (reduced sympathetic innervation, with unchanged or increased sensory innervation in endometriotic lesions) has been demonstrated in endometriosis in recent studies. And it is believed to contribute to the pathogenesis of endometriosis-associated pain. It is primarily considered to be a natural adaptive program to endometriosis-associated inflammation. However, it is important to further clarify whether other potential modulating factors are involved in this dysregulation. It is generally accepted that endometriosis is an estrogen dependent disease. Higher estrogen biosynthesis and lower estrogen inactivation in endometriosis can lead to an excess of local estrogen in endometriotic lesions. In addition to its proliferative and anti-inflammatory actions, local estrogen in endometriosis also exerts potential neuromodulatory effects on the innervation in endometriosis. The aim of this review is to highlight the role of estrogen in mediating this imbalanced sympathetic and sensory innervation in endometriosis, through direct and indirect mechanisms on sympathetic and sensory nerves. Theoretical elaboration of the underlying mechanisms provides new insights in supporting the therapeutic role of estrogen in endometriosis-associated pain.
Introduction
Endometriosis is a chronic, benign, multifactorial gynecological disease affecting millions of women of childbearing age. It is estimated that endometriosis is present in 6e10% of reproductive age women (Khan et al., 2013) and in up to 20e40% of infertile women. Among women with pelvic pain, the prevalence goes up to 50% (Giudice, 2010) . The various locations of endometriotic lesions make the patient suffer from diffuse, dull, but poorly localized feelings of pain, which are a major cause of disability and compromised quality of life in women and teenage girls (D'Hooghe and Hummelshoj, 2006) .
Growing evidences tend to support the view that abnormal innervation of endometriosis plays a crucial role in the generation of pain (Mechsner et al., 2009; Anaf et al., 2000) . There is a recently reported phenomenon in endometriosis that draws investigators' interest. Arnold et al. demonstrated an imbalance between sympathetic and sensory nerve fibers in peritoneal endometriosis (Arnold et al., 2012 (Arnold et al., , 2013 . The density of substance P positively stained sensory nerve fibers was significantly lower in the unaffected peritoneum compared to the endometriotic lesion, while the density of tyrosine hydroxylase (TH) positively stained sympathetic nerve fibers was significantly higher in the unaffected peritoneum in comparison to sympathetic nerve fiber density (NFD) in the lesion (Fig. 1 ). This imbalanced sympathetic and sensory innervation is consistent with the partial results demonstrated by Ferrero et al., in 2010 (Ferrero et al., 2010 . Their research team found out that sympathetic nerve fibers were significantly lower in the mucosal and muscular layers near the endometriotic lesions compared with the area far from the lesions, while sensory NFD was not altered in the area near the endometriotic lesions. But this phenomenon has not been investigated in ovarian endometriosis and deep infiltrating endometriosis (DIE). This imbalanced innervation is believed to contribute to the pathogenesis of peripheral neuropathic pain in endometriosis. Therefore, it is important to investigate the mechanism of this imbalanced innervation. Previous studies supposed that the imbalance between sympathetic and sensory nerve fibers in endometriosis was a natural adaptive program to endometriosis-associated inflammation (Arnold et al., 2012 (Arnold et al., , 2013 . However, further research is needed to help us have a better understanding of this imbalance.
Endometriosis is widely accepted to be an estrogen (E)-dependent disease. The dysregulation of the enzymes required to synthesize estrogen leads to the hyperestrogenism environment of endometriosis. More importantly, estrogen has been demonstrated to exert neuromodulatory effects through multiple processes (Wharton et al., 2012) . The aim of this article is to highlight the potential role of estrogen in maintaining the imbalanced sympathetic and sensory innervation in endometriosis in detail, providing a new pathophysiologic vision of estrogen in endometriosis.
The role of estrogen and its receptors in endometriosis
A review performed by Huhtinen et al. summarizing the results of a series of studies indicates that all the enzymes required to synthesize estrogen are expressed in endometriotic lesions (Rizner, 2009; Attar and Bulun, 2006) . The aberrant expression of these estrogen-metabolizing enzymes leads to higher E2 biosynthesis and lower E2 inactivation, and to an excess of local E2, which results in further proliferation of ectopic endometrium (Giudice and Kao, 2004) . Increased production of local E2 induces prostaglandin E2 (PGE 2 ) formation and then stimulates cyclooxygenase type 2 (COX-2), which in turn stimulates the expression of aromatase, establishing a positive feedback cycle to enhance E2 production (Rizner, 2009) .
There are two distinct isoforms of estrogen receptors (ERs): ERa and ERb, the actions of which are regulated by ligand availability and by the presence of various coregulators (Musgrove and Sutherland, 2009) . Estrogen stimulates the growth of endometrial cells mainly through the activation of ERa (Shang, 2006; Vivacqua et al., 2006) . But many studies have shown that both ERs contribute to stimulation of the cell cycle and promotion of endometriotic stromal cells proliferation (Harris et al., 2005; Trukhacheva et al., 2009) . Estrogens also exert anti-inflammatory functions by repressing several inflammatory genes including IL-8, IL-6, TNF-a. ERa and ERb, mainly ERa, mediate the antiinflammatory action of estrogens by inhibiting NF-kB activity and DNA binding, or by recruiting steroid receptor coactivator 2 (SRC-2) (Cvoro et al., 2008) .
Potential role of estrogen in maintaining imbalanced sympathetic and sensory innervation in endometriosis
In addition to its proliferative and anti-inflammatory actions, are there any other pathophysiologic effects of estrogen on endometriosis? Here, the potential neuromodulatory effects of estrogen on the nervous system in endometriosis will be presented. Moreover, as far as we know, this is the first review that reveals the potential role of estrogen in maintaining imbalanced sympathetic and sensory innervation in endometriosis (Fig. 2) .
Potential neuromodulatory effects of estrogen in endometriosis
Combined oral contraceptives (OCCs) are composed of estrogen (estradiol) and progestogen (progestin). It was reported that cyclic or continuous OCCs effectively reduced the baseline pain score for dysmenorrhea (Harada et al., 2008) . Other reports showed that postoperative OCCs could also reduce the frequency and severity of recurrent dysmenorrhea compared with surgery alone (Seracchioli et al., 2009 (Seracchioli et al., , 2010a (Seracchioli et al., , 2010b . Moreover, several studies showed that hormonal treatment significantly decreased the nerve fiber density in peritoneal endometriotic lesions, in comparison with lesions from women who did not receive hormone treatment (Tokushige et al., 2009) . As a consequence, estrogen is believed to be involved in the modulation of endometriosis-associated pain as well as aberrant innervation in endometriosis. Fig. 1 . Imbalanced sympathetic innervation in peritoneal endometriosis. Sympathetic nerve fiber density is significantly higher in the para-endometriotic area in comparison to that of the endometriotic lesion. Fig. 2 . Estrogen modulates the imbalanced sympathetic and sensory innervation in multifactorial mechanisms. High level of estrogen (top) acts directly on both sympathetic and sensory nerves in endometriotic lesion, partly leading to reduced sympathetic innervation and increased/unchanged sensory innervation. Estrogen also exerts up-regulation on specific molecules (such as Sema 3F, NGF, BDNF, Ntm, etc.) and induces degeneration of sympathetic nerves with preserved or increased sensory nerves. Moreover, SMCs, acting as a functional target, also respond to estrogen leading to a restricting environment for sympathetic nerve growth, but an permissive or a stabilizing environment for sensory nerve growth. In para-endometriotic area, opposite effects are induced by low level of estrogen (bottom). NGF: nerve growth factor; BDNF: brain derived neurotrophic factor; VEGF: vascular epithelial growth factor; Sema 3F: Semaphorin 3F; Ntm: neurotrimin; ANG II: Angiotensin II; SMCs: smooth muscle cells.
3.2. Effects of estrogen on sympathetic nerves 3.2.1. Direct neuromodulatory effects of estrogen on sympathetic nerves Sympathetic nerves within female reproductive system are affected by changes in the internal endocrine environment. For example, the density of myometrial sympathetic nerve fibers is greatly decreased during pregnancy and axonal regeneration is obtained soon after parturition (Haase et al., 1997) . In adult female rodents, widespread degeneration of sympathetic nerves in the myometrium is observed when the levels of estrogen peak during proestrus and estrus. However, during the metestrus and diestrus phases of the cycle, the myometrium obtained axonal regeneration with a decreasing level of estrogen (Zoubina and Smith, 2000) . Furthermore, these fluctuations of level of estrogen and consequential imbalance of sympathetic and sensory innervation in endometriotic lesions contribute to changes in endometriosisinduced vaginal hyperalgesic severity of the rats (Zhang et al., 2008) . Therefore, there is strong evidence supporting the modulatory effects of estrogen on sympathetic nerve fibers and endometriosis-associated pain.
In vivo injection of estrogen in ovariectomized (OVX) donor rats showed diminished neurite outgrowth. And ganglia obtained from the rats were responsive to estrogen added to the culture medium; while those obtained from estrogen untreated OVX rats were unresponsive. These findings indicate that some factors present in non-OVX rats with low E2 levels act on the ganglion to prevent estrogen from inhibiting neurite outgrowth. Neuritogenesis was normal in culture of ganglia from hypophysectomized OVX donors, but neurite outgrowth was attenuated once estrogen was added to the culture medium (Krizsan-Agbas and Smith, 2002) . It is considered that high level of estrogen inhibits the release of prolactin from the pituitary gland (Ronchetti et al., 2013) , thus enhancing the responsiveness of sympathetic nerve fibers to estrogen, and, eventually promoting sympathetic neurite outgrowth. In addition, a slight repellent effect by low concentrations of 17b-estradiol was also observed in cultured sympathetic nerve fibers (Klatt et al., 2012) .
In mice with low circulating estrogen, or ERa knockout mice with high estrogen, the uterus contains abundant sympathetic nerves . High circulating estrogen reduces the numbers of intact sympathetic nerve fibers in wild type mice, whereas single injection of estradiol is completely ineffective in altering nerve density in ERa knockout mice . Studies have shown that both ERa and ERb are expressed in sympathetic neurons Smith, 2002, 2003) . But estrogen acting through ERa determines the sympathetic nerve terminal branches within uterine smooth muscle target. Taken together, estrogen regulates the degeneration of sympathetic nerves partly through acting directly on sympathetic nerve fibers by combining with ERa when the myometrium is involved ).
Indirect neuromodulatory effects of estrogen on sympathetic nerve
(1) Modulation through actions on target matrix Sympathetic neurites were observed to grow closely associated to myometrial smooth muscle cells. The preferential association indicated that there existed interactions between growing neurites and specific molecules present in the cell membranes and/or surrounding the extracellular matrix (ECM) and basal lamina (Brauer et al., 1995 (Brauer et al., , 1999 (Brauer et al., , 2000 .
Except for the endometrial like cells, endometriosis-associated smooth muscle cells (SMCs) are found to be present in peritoneal endometriosis (Anaf et al., 2000; Mechsner et al., 2005) , ovarian endometrioma (Mechsner et al., 2005; Fukunaga, 2000) , and deep infiltrating endoemtriosis (van Kaam et al., 2008) . These cells constitute a considerable portion (up to 80%) of the endometriotic lesions (Mechsner et al., 2005; Barcena et al., 2011a) . It is demonstrated that estrogen receptors are expressed on these cells, providing the possibility that estrogen acts on SMCs through a ligandereceptor interaction pathway (Barcena et al., 2011a) . Previous studies have shown that sympathetic ganglion explant outgrowth is enhanced in the presence of different types of target tissues, including heart, blood vessels, intestine and vas deferens (Rawdon and Dockray, 1983; Southwell et al., 1985; Rawdon, 1991) . The presence of myometrial target from OVX donor rats in cultured sympathetic ganglion markedly increased the number of neurites compared to sympathetic ganglion cultured alone. But the neuritogenesis inducing effect exerted by myometrium is markedly inhibited by in vivo treatment of E2, which is consistent with the in vivo observations that E2 prevented normal developmental increases in sympathetic innervation in developing rats (Brauer et al., 1999) and attenuated collateral sprouting of iris sympathetic nerves into myometrial explants in oculus (Brauer et al., 2000) . Myometrial substrate-bound signals play a crucial role during development and continue to function during maturity to regulate neuronal plasticity and regeneration (Hou et al., 2008) . Further study demonstrated that alterations of myometrial substratebound signals induced by estrogen contribute to diminished myometrial supportive ability to sympathetic nerve growth (Richeri et al., 2010) . In addition, ERa is expressed in myometrial smooth muscle cells (Hiroi et al., 1999; Wang et al., 1999) and is required for E2 to elicit modulation of uterine sympathetic remodeling . SMCs contained in endometriotic lesions are also similar to the myometrial cells in the uterus. Similar to that exerted by myometrium, interactions between these SMCs and sympathetic nerves may lead to a sympathetic neuritogenesis facilitating effect, thus regulating the abnormal innervation of sympathetic nerve in endometriosis under abnormal levels of estrogen.
A possible mechanism may be involved in the induction of pathological outgrowth of sympathetic nerve fibers and subsequent hyper-innervation by SMCs. Mechanical stretch of SMCs is produced by the chaotic/irregular contractions mediated by oxytocin receptor, leading to pathophysiological stimulus within the lesions. More importantly, mechanical stretch is able to induce the growth of sympathetic neurocytes by enhancing the expression of nerve growth factor (NGF) and ciliary neurotrophic factor (CNTF) in an autocrine/paracrine manner (Rana et al., 2010) . It is believed that SMCs are more likely to originate from smooth muscle metaplasia (SMM), out of stromal cells or epithelialemesenchymal transition (EMT) (Hayashida et al., 2011) of the endometriotic cells, other than from basal stem cells or reactivated coelomic epithelial cells. As a result, SMCs close to the endometriotic lesion (intrastromal SMCs/surrounding SMCs) seem to be immature, whereby the peripheral SMCs are fully differentiated (Barcena et al., 2011a) . The contractility and subsequent mechanical stretch induced by well differentiated peripheral SMCs is much stronger than that induced by immature SMCs because mature SMCs possess a welldeveloped system of contractile myofilaments (Mouravas et al., 2010) . Therefore, sympathetic neurite outgrowth is increased to a greater degree in the peripheral area of the endometriotic lesion than that in the endometriotic lesion itself. Most interestingly, Rafik Hachani et al. demonstrated that sympathectomy of hypercholesterolemic rats not only increased sensory innervation, but also induced vascular SMC dedifferentiation with higher expression of vimentin and lower expression of h-caldesmon. This phenomenon is extremely similar to the decreased sympathetic and increased sensory innervation in peritoneal endometriotic lesion (Hachani et al., 2010) . And immature SMCs resulting from inadequate sympathetic innervation exert decreased mechanical stretch within the lesion. In contrast, it is believed that sympathetic innervation promotes SMCs differentiation in a positive feedback in paraendometriotic areas (Damon, 2005) (Fig. 3) . In a word, SMCs also act as a target of estrogen in endometriosis, leading to the loss of sympathetic innervation within the endometriotic lesions and an increased sympathetic nerve density peripheral to the lesions.
Taken together, these findings support the notion that estrogen acts directly on estrogen receptors expressed on the target endometriotic tissue, regulating sympathetic neuritogenesis in a cellecell interaction manner.
(2) Modulation through acting on specific molecules 3.2.2.1. Nerve growth factor. Nerve growth factor (NGF), known to be a neuron growth-activating factor, is highly expressed in endometriotic lesions and in peritoneal fluid from patients with endometriosis. Previous reports have indicated that NGF is required for the regenerative remodeling of the uterine sympathetic innervation after pregnancy (Varol et al., 2000) . More importantly, higher NGF expression has been proven to be correlated with a higher ratio of sensory to sympathetic nerve fibers (Arnold et al., 2012) . Under optimal conditions preferring the binding of NGF and TrkA, NGF mediates sympathetic neuronal survival and axonal growth (Kohn et al., 1999) . However, under suboptimal conditions, sympathetic neuronal apoptosis and growth cone inhibition are promoted by the combining of NGF and p75NTR (Kohn et al., 1999; Bamji et al., 1998) . Growing evidence indicates that estrogen is able to regulate the synthesis and release of NGF and its receptors (TrkA and p75NTR) through interactions with estrogen response elements that are present in promoter regions of the target gene Krizsan-Agbas et al., 2003a) . And the regulation by estrogen changes the neurotrophic environment required for maintaining the sympathetic and sensory innervation. Studies have demonstrated that estrogen reduces NGF protein content in sympathetic vascular targets, which may lead to decreased sympathetic innervations to these targets (Kaur et al., 2007) . Interestingly, opposite up-regulation of NGF in the uterus is observed when long-term estrogen is applied (Krizsan-Agbas et al., 2003b; Bjorling et al., 2002) . Acute and chronic estrogen treatment also reduced TrkA and p75NTR expression in sympathetic neurons (Hasan et al., 2005) and in endometriotic lesions (Tokushige et al., 2008) . However, there is also evidence supporting that the expression of p75NTR in uterine-projecting sympathetic neuron is promoted by estrogen (Richeri et al., 2005) . As a result, there are many controversies in different regulatory effects of estrogen on NGF and its receptors. Further studies are required to identify the distinct functions of estrogen on NGF and its receptors.
NGF is synthesized as a precursor, proNGF, which undergoes processing posttranslationally to generate mature NGF (NGF-b) (Fahnestock et al., 2004) . Studies showed that proNGF and its proteolytically processed protein products may differentially activate pro-and antiapoptotic cellular responses through preferential activation of TrkA or p75NTR (Lee et al., 2001) . Highly accumulated ProNGF in intermyometrial connective tissue layers at term pregnancy where sympathetic axon degeneration occurs may contribute to the pregnancy-related uterine degeneration (Lobos et al., 2005) . ProNGF has been shown to be neurotoxic when bound in a heterotrimer with the p75 receptor and the receptor sortilin. In vitro experiments show that proNGF is indeed neurotoxic for NGF-responsive sympathetic neurons and that blockade of sortilin rescues proNGF-induced cell death (Al-Shawi et al., 2007) . Therefore, increased proNGF in intermyometrial layers combined with increased sortilin expression in projecting sympathetic neurons may contribute to neuronal atrophy and degeneration.
Since TrkA and p75NTR are required for carrying out the modulatory effects on sympathetic neurons of NGF, downregulation of both receptors by estrogen attenuates the functions of NGF because of the limitation of saturated ligandereceptor interactions. Markedly up-regulation of NGF may be a compensatory response to the decreased sympathetic neurite outgrowth. Another explanation is that the expression pattern of NGF, TrkA and p75 is more correlated to progesterone than estrogen (Bjorling et al., 2002; Shi et al., 2006) , which indicates that estrogen and/or progesterone may act synergistically with NGF in modulating sympathetic nerve development and growth. Thirdly, up-regulated NGF prefers to promote axonal growth of sensory nerve fibers, other than inhibits mature sympathetic ganglia outgrowth in estrogenrich conditions (Krizsan-Agbas et al., 2003a; Latini et al., 2008) . Moreover, there may be other factors that can repress NGF-TrkA signaling in sympathetic neurons, limiting its neurite outgrowth promoting functions (Atwal et al., 2003) .
3.2.2.2. Semaphorin 3F. Semaphorin 3F (Sema 3F), a member of class-3 secreted semaphorins that are originally identified to as axonal guidance molecules through repulsion during the development of the nervous system (Serini et al., 2013) , has been demonstrated to be repellent for sympathetic nerves by binding to its receptor neuropilin-2 (NRP2) and co-receptor plexin A2 (Fassold et al., 2009) . Interestingly, Sema 3F can also antagonize NGF-TrkA signaling in sympathetic neurons (Atwal et al., 2003) . In vivo and in vitro studies have shown that NRP2 is required in mediating the repulsive axonal responses to Sema 3F (Fassold et al., 2009; Chen et al., 2000; Waimey et al., 2008) .
Estrogen provokes a tissue-specific induction of Sema 3F, which prefers to locate in the hypertrophic connective tissue separating smooth muscle bundles and surrounding major blood vessels (Richeri et al., 2011) . Estrogen treatment of OVX rats decreased uterine NRP2 mRNA levels (Northern blot analysis) approximately 40% compared with those without treatment (Pavelock et al., 2001 ). In contrast, another study suggested that estrogen induced the expression of NRP2 (immunohistochemistry analysis) in uterine nerves (Richeri et al., 2011) . At the end of chronic estrogen treatment, no TH positively stained intrauterine perivascular nerves were visible. And simultaneous immunostaining of NRP2 and TH demonstrated no TH-immunoreactivity in these NRP2 positively stained nerve fibers, which suggested NRP2 might be expressed in sympathetic nerves only after the loss expression of TH during the estrogen-induced sympathetic degeneration (Kitawaki et al., 2002) . Therefore, up-regulation of Sema 3F and aberrant modulation of NRP2 also contribute to estrogen inducing sympathetic nerve fiber repulsion, possibly through antagonizing potential axonal promoting factors or complicated sequential loss and gain of modulators on sympathetic nerves.
3.2.2.3. Brain derived neurotrophic factor. Brain derived neurotrophic factor (BDNF) can exert potential suppression of sympathetic neuritogenesis in myometrium, but the underlying mechanisms are unclear (Krizsan-Agbas et al., 2003b) . One possible pathway is that BDNF activates p75NTR, leading to the production of ceramide, which induces neuronal apoptosis (Bamji et al., 1998) and inhibits axonal elongation (Rice et al., 1998) . Estrogen injection of OVX rats could increase the level of BDNF in myometrium and endometrium. Further in vitro experiments showed that BDNF was required for estrogen to suppress sympathetic neurite outgrowth (Krizsan-Agbas et al., 2003a) . However, BNDF neutralization fails to fully reverse estrogen's effects, suggesting that additional targetderived factors also participate.
3.2.2.4. Neurotrimin. Neurotrimin (Ntm) is a neural cell adhesion molecule that is present in the uterus. In uteri of rats at estrus, when sympathetic innervation density is low, Ntm staining was markedly increased in circular and longitudinal smooth muscle. Moreover, in vivo experiments showed that myometrial Ntm mRNA and protein were up-regulated 6 h after estrogen administration. Estrogen also decreased neurite outgrowth in smooth muscleeneuron cocultures, indicating an unsuitable condition for sympathetic neurite growth induced by estrogen. Furthermore, Ntm knockdown impaired estrogen's ability to reduce sympathetic innervation (Krizsan-Agbas et al., 2008) . Collectively, Ntm may also potentially act as a target mediated by estrogen that exerts repellent effects on sympathetic innervation in endometriosis.
3.2.2.5. Artemin. Artemin, a member of the glial cell-derived neurotrophic factor (GDNF) (Warnecke et al., 2010) , acts as a guidance molecule for the growth of sympathetic nerve fibers along blood vessels in many tissues (Honma et al., 2002) . The migration and axonal projection of sympathetic nerve fibers, other than sensory nerve fibers, are severely impacted with knockouts of artemin or its receptor GFRa (Honma et al., 2002) . The expression of artemin in endometriosis is not reported yet, but it is demonstrated to be increased in endometrial carcinoma (Kang et al., 2010) . Recently, the expression of artemin is shown to be positively correlated to the ER status in human mammary carcinoma, indicating an estrogeninducible characteristic of artemin. The circumstantial evidence suggests that estrogen might also play a role in regulating artemin in endometriosis. Therefore, the alteration of artemin expression results in the inhibition of sympathetic neuritogenesis in endometriotic lesions. However, this hypothesized theory needs further verification.
3.2.2.6. Other potential specific molecules. Vascular epithelial growth factor (VEGF)，some inflammatory factors such as IL-6 (Canellada et al., 2008) or TNF-a (Velasco et al., 2006) are also regulated by estrogen, and may also play important roles in regulating abnormal sympathetic and sensory innervation in endometriosis. Additional investigations need to be performed to further verify these hypotheses.
3.3. Effects of estrogen on sensory nerves 3.3.1. Direct effects of estrogen on sensory nerves in endometriosis Nociceptive sensory nerve hyperinnervation is implicated in some female pain syndromes, including interstitial cystitis, vulvodynia, irritable bowel syndrome and breast pain (Pang et al., 1995; Bohm-Starke et al., 1998; Gopinath et al., 2005) . ERa and ERb are also expressed on sensory neurons, which indicates that estrogen may also affect sensory axonal outgrowth through acting directly on the neuron (Taleghany et al., 1999; Papka and Storey-Workley, 2002) . In fact, there are only a few studies that specially investigate direct effects of estrogen on sensory nerves. Blacklock et al. demonstrated that chronic estrogen elevation induced selective proliferation of rat mammary gland calcitonin gene related peptide (CGRP) positively stained sensory nerve fibers . But this proliferative effect was restricted to nerves around the blood vessels, which served as nociceptors that induced a vasodilatory function. However, the sensory of the nipple and adjacent skin was not significantly affected, which was consistent with the findings from the study of Traurig et al. (Traurig et al., 1984) . These observations suggested that sensory nerves might respond to fluctuation of estrogen levels in a target specific pattern. Later on, Blacklock et al. found that estrogen exerted by direct effects on nociceptor neurons to promote axon outgrowth via an NGF-independent mechanism, instead of eliciting nociceptor hyperinnervation by promoting targeted release of neurotrophic factors (Chakrabarty et al., 2008) . Accordingly, cellular and molecular mechanisms responsible for estrogen-regulating sensory innervation are still poorly understood.
3.3.2. Indirect neuromodulatory effects of estrogen on sensory nerves in endometriosis 3.3.2.1. Smooth muscle cells. However, regulatory effects of estrogen on target tissue or the target derived trophic factors may also influence sensory neuritogenesis (Bjorling et al., 2002; Albuquerque et al., 1998) . The irregular contraction of endometriosis-associated smooth muscle cells caused by local inflammation stimulates the nociceptors (sensory nerve fibers) within the lesion, thus generating endometriosis-associated pain (Mechsner et al., 2005; Odagiri et al., 2009 ). Similar to the myometrial cells in the uterus, estrogen receptors are also expressed on these smooth muscle cells, indicating that these cells might also act as a direct functional target of estrogen (Barcena et al., 2011a) .
3.3.2.2. Nerve growth factors. The overexpression of nerve growth factor (NGF) in peritoneal fluid from women with endometriosis also plays an important role in sensory neurite outgrowth. Treatment with NGF inhibitor (both anti-NGF and K252a) can inhibit neuritogenesis of dorsal root ganglion (DRG) (Barcena et al., 2011b) . Another research demonstrated that transfection of rats with surgically induced endometriosis using specific b-NGF siRNA decreased the density of CGRP and SP immunoreactive sensory nerve fibers in the implants (Chen et al., 2014) as well as density of nerve fibers stained with NGF, TrkA, and NGFRp75. In fact, estrogen was shown to increase levels of the TrkA in sensory nerves (Sohrabji et al., 1994; Lanlua et al., 2001) . As a result, up-regulation of NGF in endometriosis induced by estrogen can stimulate the sensory neurite outgrowth, which may be involved in the increased sensory innervation in peritoneal endometriotic lesions.
3.3.2.3. Semaphorins. Semaphorin 3F is known to be a repellent of sympathetic nerve fibers (Chen et al., 2000 (Chen et al., , 1998 , but there are no studies exploring its role in regulating sensory neurite outgrowth in endometriosis. However, expressions of other semaphorins (such as Sema 3A, a repellent factor of both sympathetic and sensory nerve fibers (Kawasaki et al., 2002; Long et al., 2009; Graf et al., 2012) ) in endometriosis may play potent roles in regulation the abnormal sensory innervation in endometriosis. Additional studies are needed to figure out the relationship of estrogen and these repellent factors, and whether the aberrant expression of these factors contributes to the imbalance of sympathetic and sensory innervation in endometriosis.
3.3.2.4. Angiotensin Ⅱ. Angiotensin II (ANGII), the major biologically active endogenous ligand of renin-angiotensin system (RAS), is present in the lumber dorsal root ganglion (DRG) of adult rats (Patil et al., 2010; Smith et al., 2013; Muralidharan et al., 2014) . Locally synthesized ANGII can induce estrogen-mediated sensory DRGs neurite outgrowth through activating ANGII type 2 receptor (AT 2 R), a receptor co-localized with DRG sensory neurons and upregulated by estrogen (Chakrabarty et al., 2008) . ANGII signaling via the AT 2 R induces neurite outgrowth in cultured cells of neuronal origin via a mechanism involving nerve growth factor (NGF)-independent phosphorylation of the neurotrophic tyrosine kinase A receptor (TrkA) (Plouffe et al., 2006) . PD123,319, a selective AT 2 R blocker, can eliminate estrogen-mediated DRG neurons sprouting in vitro, further supporting that AT 2 R plays a central role in E2-induced axon sprouting (Chakrabarty et al., 2008) . Moreover, AT 2 R up-regulation by estrogen also promotes hyperinnervation in cutaneous, glandular, and vascular targets in vivo . Eutopic endometrium can produce ANGII through local angiotensin-converting enzyme (ACE) activity (Ahmed et al., 1995) , but the role of locally synthesized ANGII remains speculative. After ectopic transplantation, ANGIIactivating AT 2 R may also play an essential role in estrogenpromoting sensory hyperinnervation in endometriotic lesions.
3.3.2.5. Brain derived neurotrophic factor. BDNF inhibits the axonal outgrowth from small dorsal root ganglion neurons in culture (Gavazzi et al., 1999) through acting on the p75NTR expressed on sensory nerves (Mu et al., 1993) . But the sensory nerves do not degenerate in the uterine after the level of estrogen was elevated, which makes it uncertain how estrogen affects the sensory innervation.
3.3.2.6. Other potential specific molecules. Ntm promotes outgrowth of resident sensory nerves as well as stabilizes sensory axons, thus ensuring the preservation of sensory innervation (Krizsan-Agbas et al., 2008) . Inflammatory factors as well as immune factors in response to up-and-down levels of estrogen also play an important role in regulating sensory neurite outgrowth. Due to a large number of these factors and various complicated functions involved in this process, we will not present and discuss them here in further detail.
Conclusion
Locally higher E2 biosynthesis and lower E2 inactivation, as well as aberrant expression of ERa and ERb in endometriosis further support the estrogen-dependent characteristic of endometriosis. Except for its proliferative and anti-inflammatory actions, estrogen also exerts neuromodulatory functions through direct or indirect mechanisms on sympathetic and sensory nerves. The major outcome is reduced sympathetic innervation, with unchanged or increased sensory innervation in endometriotic lesions. Taken all these evidences together, we propose that estrogen acts as an important potent modulator that maintains this imbalanced sympathetic and sensory innervation in endometriosis. Estrogen regulates multiple aspects of the endometriotic microenvironment to selectively induce the repulsion of sympathetic axon while preserving sensory innervation. However, other mechanisms underlying this complicated pathophysiological process still remain to be further studied. It is also important to discover new neuromodulatory targets of estrogen in the future, providing more evidence elucidating this dysregulation of sympathetic and sensory innervation in endometriosis.
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